Form 8.3 - UDG Healthcare plc

RNS Number : 0431E

Standard Life Aberdeen plc

02 July 2021

 

Ap19

FORM   8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.  KEY   INFORMATION

Nameofpersondealing (Note 1)	Standard Life Aberdeen plc
Companydealtin	UDG Healthcare plc
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)	€0.05 ordinary shares
Date of dealing	01 July 2021

2.  INTERESTS AND SHORT POSITIONS

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

	Long			Short
	Number		(%)	Number		(%)
(1)Relevantsecurities	3,342,703 (1.33%)
(2) Derivatives (other than options)
(3)Optionsandagreementstopurchase/sell
Total	3,342,703 (1.33%)

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   3)

Classofrelevantsecurity:	Long			Short
	Number		(%)	Number		(%)
(1)Relevantsecurities
(2) Derivatives (other than options)
(3)Optionsandagreementstopurchase/sell
Total

Ap20

1.  DEALINGS  (Note   4)

(a)  Purchases and sales

Purchase/sale	Numberofrelevantsecurities	Priceperunit (Note 5)
Sale	18,939	GBP 10.690
Sale	4,219	GBP 10.690

(b)  Derivatives transactions (other than options transactions)

Productname, e.g. CFD	Natureoftransaction (Note 6)	Numberofrelevantsecurities (Note 7)	Priceperunit (Note 5)

(c)  Options transactions in respect of existing relevant securities

(i)  Writing, selling, purchasing or varying

Productname, e.g. call option	Writing, selling,purchasing,varyingetc.	Numberofsecurities towhichtheoptionrelates (Note 7)	Exercise price	Type, e.g.American,Europeanetc.	Expiry date	Optionmoney paid/receivedperunit (Note 5)

(ii)  Exercising

Productname, e.g. call option	Numberofsecurities	Exercisepriceper unit (Note 5)

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2.  OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any 

other person relating to the voting rights of any relevant securities under any option referred to on this form 

or   relating   to   the   voting   rights   or   future   acquisition   or   disposal   of   any  relevant securities to which any derivative 

referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached?  (Note   9)    NO

Dateofdisclosure	2 July 2021
Contact name	Vikas Sharma
Telephone number	[phone]
If aconnectedEFM,nameofofferee/offerorwithwhichconnected
If aconnectedEFM,statenatureofconnection (Note 10)

 

END

 

 

ISEEAFXAEENFEFA